Monday, 26 June 2017

Generics News

  • Lupin gets FDA nod to make generic insomnia drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013

    Singapore: The US FDA provided its final approval to Indian drug maker Lupin to manufacture and market a generic version of Sanofi Aventis' Ambien CR extended release tablets. Zolpidem Tar...Read more

  • Aurobindo Pharma files ANDA for HIV generic drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2015

    Singapore: India's Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for tentative approval to the Food and Drug Administration (FDA), for the...Read more

  • Canadian generic maker enters Korea with JV

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013

    Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint venture (JV) with Seoul-based Korea Kolmar Holdings. Pharmascience pla...Read more

  • Orexigen, Takeda file lawsuit against Actavis for patent infringement

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2015

    Singapore: Orexigen Therapeutics and Takeda Pharmaceuticals have filed a lawsuit in US against Actavis for filing an abbreviated new drug application (ANDA) to market and sell generic versi...Read more

  • FDA warns Tianjin Zhongan for cGMP lapses

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2014

    Singapore: The US Food and Drug Administration (FDA) has slapped a warning letter to China based Tianjin Zhongan Pharmaceutical company for manufacturing adulterated active pharmaceutical ...Read more

  • Beximco pharma receives TFDA approval

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2014

    Singapore: Beximco pharmaceuticals, a Bangladeshi pharma giant announced that it had received Good Manufacturing Practices approval from the Taiwan Food and Drug Administration (TFDA). The ...Read more

  • Teva to acquire migraine drug firm at $825 mn

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014

    Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmaceutical, is set to acquire biotechnology company focused on treatment...Read more

  • Mayne Pharma appoints a new vice president

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2014

    Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business development, for its US generic products division. The company spokesperson sa...Read more

  • GSK seeks FIPB nod to hike stake in India

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2014

    Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake in its domestic arm by buying 24.33 percent for an estimated Rs 6,400...Read more

  • Pharma FDI cap, right move for India

    Generics |  Opinion | By Nandita Singh | 0 Comment | 31 Jul, 2012

    India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brownfield foreign direct investment in pharma at 49 percent, allaying fea...Read more

  • GSK CEO: London HQ 'knew nothing' of the fraud

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013

    Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest drugmaker, GlaxoSmithKline, the company's CEO Sir (Dr) Andrew Witty ha...Read more

  • FDA nod for Lupin's angina generic Ranolazine

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013

    Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg from the US FDA. Lupin's Ranolazine extended-release tablets are th...Read more

  • Eli Lilly files $500 mn suit against Canada govt

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013

    Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the country's courts unfairly threw out these patents when challenged by ge...Read more

  • DRL launches Alchemia thrombosis generic in India

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2013

    Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant product fondaparinux in India. This is the first time fo...Read more

  • Abbott Laboratories unveils strategy for India

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013

    Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push its best brands and focus on nutrition and over-the-counter drug port...Read more

  • Pfizer to acquire Innopharma at $360 mn

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2014

    Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, injectable and ophthalmic products. InnoPharma's current portfolio inc...Read more

  • Mylan launches operations in India with 18 ARV products

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012

    Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) produ...Read more

  • Mundipharma appoints John Lee as GM for SEA

    Generics |  Influencers | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2013

    Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, to the position of general manager for South Korea and South East Asia...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls